MANKIND:NSE
Mankind Pharma Ltd
₹2,475.00
arrow_downward
-0.25%(-6.20) 1D
Nov 3, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MANKIND...
Open
₹2,500.00
High
₹2,500.00
Low
₹2,461.10
Mkt. cap
1.02T
Avg. vol.
741.79K
Volume
770.95K
P/E ratio
45.61
52-wk high
₹2,642.00
52-wk low
₹1,909.70
EPS
₹54.27
No. of employees
20K
Open
₹2,500.00
High
₹2,500.00
Low
₹2,461.10
Mkt. cap
1.02T
Avg. vol.
741.79K
Volume
770.95K
P/E ratio
45.61
52-wk high
₹2,642.00
52-wk low
₹1,909.70
EPS
₹54.27
No. of employees
20K
News stories
From web sources and news partners
Local 3 News
·
1 hour ago
RAW: NYSE: OPENING BELL (TUESDAY)
Investing News Network
·
6 minutes ago
NYSE-Affiliated Venue for Tokenization Adds Transfer Agents: NYSE Content Update
Bloomberg.com
·
51 minutes ago
Goldman’s Molavi Says 60% of S&P 500 Is in Bear Market Territory
Fox Business
·
1 hour ago
Midterm elections historically trigger S&P 500 gains 100% of the time
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20.5K
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitemankindpharma.com